Similarly, depletion of TSPAN8 or ATXN3 in primary cancer cells derived from breast cancer patients decreased these cells sphere formation efficiency and enhanced their sensitivity to chemotherapeutic agents (Supplementary Fig. 5a, b). The gene discussed is ATXN3; the disease is cancer.